Phytochemical and Pharmacological Properties of Phyllanthus niruri L: A Comprehensive Review

Author:

B. Sreedevi1, C. Raja Kumar2 and P. Sashikiran3

Journal Name: Biological Forum – An International Journal, 15(6): 1095-1100, 2023

Address:

1Department of Zoology, SVGM Government Degree College, Kalyandurg (Andhra Pradesh), India.

2Department of Botany, Government Degree College, Huzurabad (Telangana), India.

3Department of Botany, SVGM Government Degree College, Kalyandurg (Andhra Pradesh), India.


DOI: -

PDF Download PDF

Abstract

Phyllanthus niruri L., also known as "Bhumi Amla" or "Stonebreaker," is a small herb from the Phyllanthaceae family found in tropical and subtropical regions. It has long been used in traditional medicine systems like Ayurveda for treating various conditions such as jaundice, kidney stones, liver problems, and viral infections. The plant is rich in phytochemicals like alkaloids, flavonoids, terpenoids, and saponins and has a high carbohydrate and fiber content. Recent research has validated many traditional uses of Phyllanthus niruri, showing its effectiveness in protecting the liver, fighting viruses, microbes, and inflammation, as well as lowering uric acid and cholesterol levels. It also shows potential for reducing oxidative stress, boosting immune function, and managing metabolic disorders. However, further research is needed to standardize dosages, improve extraction methods, and gather more safety data for clinical applications. Despite these limitations, Phyllanthus niruri holds promise as a cost-effective and beneficial treatment option with numerous health benefits.

Keywords

Phyllanthus niruri, Phytochemicals, Pharmacological properties, Hepatoprotective, Antiviral therapy.

Introduction

In the traditional system of medicine, a number of plants have been widely used for the treatment of various disorders since ancient times. The knowledge pertaining to these medicinal plants was handed down from generation to generation either orally or through documents and effective plants have been selected by trial- and error-based experiments (Wansi et al., 2019). In fact, plants have various applications, especially in the health, agriculture, food, and cosmetic industries (Mohammad Hosseini et al., 2019). In Ayurveda system of medicine, Phyllanthus niruri Linn (Tamalaki in Sanskrit) is one of the herbs mentioned in all the relevant ancient Ayurvedic texts. This plant belongs to the family Euphorbiaceae and is an annual herb that is widely spread throughout the tropical and subtropical countries of the world including Sri Lanka and India and commonly found as weed in both cultivated and wasteland areas particularly in the rainy season.

A number of research studies have confirmed that Phyllanthus niruri is rich in phytochemicals, such as alkaloids, flavonoids, ellagitannins (including corilagin and geraniin), and lignans (like phyllanthin and hypophyllanthin). These compounds contribute to its various pharmacological benefits, which encompass hepatoprotective, nephroprotective, antioxidant, anti-inflammatory, antidiabetic, and antiviral properties. Notably, Phyllanthus niruri has gained recognition as a plant with significant therapeutic value, particularly for its effectiveness in inhibiting the formation of kidney stones and combating the Hepatitis B Virus (HBV) (Dhawan & Olweny 2020).

Description: Phyllanthus niruri is a small herb that typically grows between 30 to 60 cm in height. The stem is smooth and often branches out at the base. The leaves are numerous, small, green, and arranged alternately along the stem. They are elliptic or oblong with short petioles. The tiny yellowish flowers are plentiful and monoecious, with male blooms featuring one to three stamens and female flowers usually solitary. The fruit is a smooth, depressed globose capsule measuring 2-3 mm in diameter. The plant has horizontal branches reaching heights of 30 to 60 cm and widths of 1 to 2.5 mm, with a dense branching pattern.

Botanical Classification:

Phyllanthus niruri: Benefits, uses, and risks

Kingdom - Plantae;  Division - Magnoliophyta;  Class - Magnoliopsida; Order - Euphorbiales; Family - Euphorbiaceae; Genus - Phyllanthus; Species - Niruri

Table 1: Major phytoconstituents of Phyllanthus niruri and their reported pharmacological activities.

Class

Compound(s)

Reported Pharmacological Properties

References

Alkaloids

4-methoxy-nor-securinine, Nirurine, Ent-norsecurinine

CNS stimulant, antimicrobial, antimalarial-like activity

(Calixto et al., 1998; Srivastava & Shukla, 2010)

Benzenoids

Gallic acid

Potent antioxidant, hepatoprotective, anti-inflammatory

(Kumar et al., 2014; Lim et al., 2016)

Coumarins

Ellagic acid, Ethyl brevifolin carboxylate, Methyl brevifolin carboxylate

Antiviral (HBV, HCV), anticancer, antiurolithiatic, anti-inflammatory

(Notka et al., 2004; Lin et al., 2013)

Flavonoids

Quercetin, Rutin, Astragalin, Quercitrin, Isoquercitrin, Kaempferol glycosides, Nirurin, Gallocatechin, Niruriflavone, Quercetol

Antioxidant, hepatoprotective, antihyperlipidaemic, antidiabetic, cardioprotective

(Bagalkotkar et al., 2006; Akinmoladun et al., 2018)

Lignans

Phyllanthin, Hypophyllanthin, Niranthin, Nirtetralin, Phyltetralin, Hinokinin, Lintetralin, Isolintetralin, Linnanthin, Nirphyllin, Phyllnirurin, Demethylenedioxyniranthin

Potent hepatoprotective (anti-HBV), immunomodulatory, antioxidant, anti-inflammatory, anticancer

(Venkateswaran et al., 1987; Lee et al., 2016)

Tannins

Geraniin, Repandusinic acid, Corilagin

Strong antiviral (anti-HBV, anti-HIV), hepatoprotective, nephroprotective, antioxidant

(Yang et al., 2007; Notka et al., 2004)

Triterpenes

Limonene, p-Cymene, Lupeol acetate, Lupeol, Phyllanthenol, Phyllanthenone, Phyllantheol, Hexamethyl-tetracoshenen-1-ol

Anti-inflammatory, hepatoprotective, anticancer, antimicrobial

(Ghosh et al., 2014; Calixto et al., 1998)

Sterols

β-sitosterol, Estradiol, Isopropyl-24-cholesterol

Anti-inflammatory, hypocholesterolemic, anticancer, immunomodulatory

(Awad et al., 2000; Patel et al., 2011)

Phytallates

Phyllester

Hepatoprotective, antioxidant

(Bagalkotkar et al., 2006; Tewari et al., 2017)

Lipids

Ricinoleic acid

Anti-inflammatory, analgesic, skin protective

(Vieira et al., 2001; Calixto et al., 1998)

Saponins

Diosgenin

Anticancer, anti-inflammatory, antidiabetic, cholesterol-lowering

(Jesus et al., 2016; Lim et al., 2016)

Miscellaneous

β-glucogallin, 1-O-galloyl-6-O-luteoyl-α-D-glucose, Niruriside, Triacontanal, Tricontanol

Antioxidant, hepatoprotective, growth-promoting, antimicrobial

(Patel et al., 2011; Srinivasan et al., 2014)

(Adapted and expanded from Calixto et al., 1998; Bagalkotkar et al., 2006; Patel et al., 2011; Lim et al., 2016, with additional references)

Pharmacological Properties. P. niruri's antidiabetic effects are attributed to its ability to regulate glucose metabolism, enhance insulin sensitivity, and protect against oxidative stress through various mechanisms. These include boosting insulin secretion from pancreatic β-cells, improving insulin sensitivity in peripheral tissues, inhibiting carbohydrate-digesting enzymes like α-amylase and α-glucosidase to lower postprandial hyperglycemia, nurturing pancreatic islet regeneration and restoring islet cell structures, as well as reducing oxidative stress for better β-cell function and decreased insulin resistance (Prasad et al., 2011).

Nephroprotective. Elevated blood sugar levels can lead to the production of reactive oxygen species (ROS), causing cell damage through oxidative stress. This process is a key factor in the development of diabetic nephropathy, ultimately leading to end-stage kidney failure. Research has shown that the aqueous leaf extract of P. niruri can protect the kidneys in male Wistar rats with diabetes. The study revealed that essential kidney enzymes - SOD, CAT, and glutathione peroxidase - were preserved, while lipid peroxidation was reduced. The extract effectively prevented oxidative damage by maintaining enzyme functionality (Giribabu et al., 2014).

Hepatoprotective Activity. Phyllanthus niruri L. is renowned for its hepatoprotective properties, particularly in guarding against liver damage caused by chemical exposure and viral hepatitis. With a history rooted in traditional medicine practices such as Ayurveda, this plant has been utilized as a remedy for jaundice and chronic liver ailments. Various studies have demonstrated that extracts of P. niruri, including aqueous, ethanolic, and methanolic versions, offer substantial defense against hepatotoxins such as carbon tetrachloride (CCl₄), paracetamol, and ethanol. These extracts have been shown to significantly reduce levels of liver enzyme markers like AST, ALT, ALP, and bilirubin in the bloodstream, while also restoring the healthy structure of hepatic tissues (Sharma et al., 2011; Venkateswaran et al., 1987). The hepatoprotective effects of this substance are mainly attributed to its bioactive components, including flavonoids, lignans (such as phyllanthin and hypophyllanthin), and tannins. These compounds play a vital role in enhancing antioxidant defense mechanisms. These phytochemicals function by scavenging free radicals, diminishing lipid peroxidation, and boosting antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), which helps alleviate oxidative stress in hepatic cells (Syamasundar et al., 1985; Harish & Shivanandappa 2006). Additionally, P. niruri demonstrates antiviral hepatoprotective effects, especially against the hepatitis B virus (HBV).Research conducted both in vitro and in vivo has demonstrated that plant extracts reduce HBV surface antigen expression and inhibit the activity of viral DNA polymerase, leading to a decrease in viral replication (Lee et al., 1996). These findings have been bolstered by clinical trials demonstrating that oral administration of P. niruri extract in patients infected with HBV results in significant reductions in viral DNA levels and improvements in liver function markers, thereby validating its use in traditional medicine for managing viral hepatitis (Thyagarajan et al., 1988; Wang et al., 2014). Taken together, these results underscore P. niruri as a potential hepatoprotective agent that connects traditional medical wisdom with contemporary pharmacological evidence.

Antiviral Activity. Research findings indicate that extracts derived from Phyllanthus niruri possess notable antiviral properties, particularly in combating the hepatitis B virus (HBV). Studies have shown that the bioactive lignans present in this plant extract have the ability to inhibit HBV DNA polymerase and reduce the expression of viral surface antigens, effectively suppressing viral replication (Lee et al., 1996). Its effectiveness in blocking HBV and other viral pathogens is further validated by in vitro and in vivo models (Venkateswaran et al., 1987). Clinical trials showed that patients infected with HBV who were treated with P. niruri extracts experienced significant reductions in HBV DNA and improvements in liver function (Thyagarajan et al., 1988). The results confirm its conventional use as an antiviral agent and endorse its therapeutic potential in contemporary medicine.

Antioxidant Activity. New research has demonstrated that Phyllanthus niruri is a potent antioxidant, with both aqueous and ethanolic extracts displaying substantial free radical scavenging capabilities in DPPH and ABTS tests. Additionally, these extracts exhibit impressive ferric-reducing antioxidant power (FRAP) in laboratory conditions (Radha & Saranya 2020). A study utilizing P. niruri extracts to aid in the production of silver nanoparticles showed notable DPPH radical-scavenging capabilities similar to those of ascorbic acid. This highlights its role in promoting redox balance improvement (Preeja et al., 2020). Standardized methanol-water extracts exhibited a high total phenolic and flavonoid content, with IC₅₀ values in DPPH and ABTS assays that are remarkably low, indicating a strong antioxidant potential (Anonymous, 2017). Phyllanthus niruri L Whole-plant extracts have recently demonstrated a significant ability to scavenge ABTS and DPPH, along with effectively inhibiting superoxide and nitric oxide, highlighting their in vitro antioxidant effectiveness. These results underscore the substantial antioxidant potential of P. niruri, supporting its value both as a traditional remedy and a promising pharmacological option.

Antidiabetic Activity. Recent in vivo studies demonstrate that leaf extracts of Phyllanthus niruri significantly lower elevated serum glucose levels in alloxan-induced diabetic mice, confirming a notable hypoglycemic effect. In rats that were obese and diabetic due to streptozotocin induction, hyperglycemia was significantly alleviated and lipid profiles improved with oral administration of the extract (500 mg/kg), demonstrating effective metabolic modulation (Metabolomics study, 2016). Aqueous and ethanolic extracts were found to inhibit α-glucosidase in vitro, with IC₅₀ values of approximately 3.7 and 6.3 µg/mL, respectively. Corilagin and repandusinic acid A were recognized as strong inhibitors, with IC₅₀ values of approximately 0.9 and 1.9 µM. According to Santwana Rani and Baidyanath Kumar (2015) the extracts promote glucose uptake in muscle cells and encourage adipogenesis in adipocytes, both of which indicate enhanced glucose utilization. Together, these results emphasize P. niruri's diverse potential as an antidiabetic agent, corroborating its traditional applications and contemporary pharmacological prospects.

Anti-inflammatory Activity of Phyllanthus niruri extracts have been found to demonstrate significant anti-inflammatory properties by blocking inflammatory markers such as TNF-α, IL-1β, and IL-6 in laboratory experiments as well as in living organisms. (Rajeshkumar et al., 2020). The plant plays an immunomodulatory role by inhibiting the production of nitric oxide (NO) and the expression of cyclooxygenase (COX-2) in LPS-stimulated macrophages (Rani & Sharma 2021). Leaf extracts high in lignans (phyllanthin, hypophyllanthin) decrease NF-κB activation and lessen inflammation mediated by reactive oxygen species (Chowdhury et al., 2022). Animal models demonstrated a reduction in carrageenan-induced paw edema and an improvement in antioxidant status after treatment with P. niruri extract.

Anticancer Activity. The leaf and aerial parts of Phyllanthus niruri show anti-proliferative properties and improve the responsiveness of resistant breast cancer cells to doxorubicin. Particularly, a CH₂Cl₂ fraction notably reduced the effectiveness of DOX in MCF-7ADR cells while maintaining a moderate level of independent cytotoxicity (Rajeshkumar et al., 2021; Lee et al., 2022). Isolated lignans, such as phyllanthin and hypophyllanthin, complemented the effects of doxorubicin by enhancing apoptosis and blocking autophagy evasion. This highlights the significance of utilizing bioactive compounds derived from leaves as adjuncts in treatment (Yang et al., 2020; Tan et al., 2021). George et al. (2020) found that a standardized dry extract triggered caspase-3-dependent apoptosis in hepatocellular carcinoma cells (HepG2, Huh-7) without affecting normal hepatocytes, highlighting its specific anti-cancer properties. Phenolics and lignans such as phyllanthin, hypophyllanthin, and nirtetralin obtained from leaves have been shown to effectively induce cell-cycle arrest and apoptosis in various cancer models including lung, prostate, and breast cancer (Rizvi et al., 2021). Recent nano formulations incorporating P. niruri leaf extract (such as ZIF-8 nanocarriers) improve delivery and therapeutic efficacy, providing modern pharmacological translation strategies.

Immunomodulatory Activity. Phyllanthus niruri has demonstrated considerable immunomodulatory potential by influencing both innate and adaptive immune responses (Gupta et al., 2020). Its extracts enhance the phagocytic activity of macrophages, the function of natural killer (NK) cells, and cytokine production, thereby strengthening host defense (Meena et al., 2021). Plant-derived bioactive lignans and flavonoids help adjust the Th1/Th2 balance, leading to improved immune regulation during infections and inflammation (Das et al., 2022). Research carried out in controlled environments has shown that while there is an increase in IL-10, excessive pro-inflammatory cytokines (TNF-α, IL-6) are reduced. This suggests a dual function in maintaining immune balance. This has led to P. niruri being viewed as a promising phytomedicine for treating immunological disorders and bolstering immune resilience.

Antimalarial Activity. In tropical and subtropical regions, including many African countries, Phyllanthus has been utilized by people as an antimalarial remedy. Research conducted in laboratory settings has revealed that both aqueous and ethanol extracts of P. niruri effectively impede the growth of Plasmodium falciparum, showcasing notable IC50 values. Additionally, experiments on animal models infected with Plasmodium have indicated a decrease in parasitemia levels and an improvement in survival rates upon administration of P. niruri extracts. Consequently, there is evidence to suggest that P. niruri may complement the effectiveness of traditional antimalarial medications such as chloroquine or artemisinin, potentially enable the use of lower dosages and minimize adverse effects (Maia et al., 2020).

Conclusion

The diverse pharmacological benefits of Phyllanthus niruri, including its anti-cancer, anti-inflammatory, anti-urolithiatic, and immunomodulatory properties, can be largely attributed to its robust phytochemical composition containing lignans, flavonoids, alkaloids, and phenolic compounds. The plant's ability to regulate crucial cellular processes like apoptosis, reduce oxidative stress, modulate cytokines, and dissolve crystals is supported by evidence from both lab experiments and clinical research, validating its extensive use in traditional medicine. Additionally, advancements in drug delivery methods such as nano formulations are enhancing its efficacy and potential for practical application. In summary, P. niruri presents itself as a promising herbal remedy that bridges traditional wisdom with contemporary pharmacology, underscoring the significance of further clinical trials and molecular investigations to ascertain its standardized, safe, and efficient usage in modern healthcare practices.

References

Akinmoladun, F. O., Komolafe, T. R., Olaleye, T. M., Komolafe, O. O., Farombi, E. O., & Komolafe, T. R. (2018). Antioxidant and hepatoprotective potential of flavonoids: Current evidence and future perspectives. Journal of Food Biochemistry, 42(5), e12525.

Anonymous (2017). Phyllanthus niruri standardized extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in Sprague–Dawley rats. [Journal Article].

Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Supuran, C. T., & International Natural Product Sciences Taskforce. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews Drug Discovery, 20(3), 200–216.

Awad, A. B., Chan, K. C., Downie, A. C., & Fink, C. S. (2000). Peanuts as a source of β-sitosterol, a sterol with anticancer properties. Nutrition and Cancer, 36(2), 238–241.

Bagalkotkar, G., Sagineedu, S. R., Saad, M. S., & Stanslas, J. (2006). Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: A review. Journal of Pharmacy and Pharmacology, 58(12), 1559–1570.

Calixto, J. B., Santos, A. R., Filho, V. C., & Yunes, R. A. (1998). A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential. Medicinal Research Reviews, 18(4), 225–258.

Chowdhury, A., Gupta, S., & Dutta, S. (2022). Lignans from Phyllanthus niruri attenuate NF-κB activation and oxidative stress in inflammatory pathways. Phytomedicine, 95, 153883. 

Dhawan, S., & Olweny, E. O. (2020). Phyllanthus niruri (stone breaker) herbal therapy for kidney stones; a systematic review and meta-analysis of clinical efficacy, and Google Trends analysis of public interest. The Canadian Journal of Urology, 27(2), 10162–10166.

Das, S., Roy, P., & Mandal, S. (2022). Bioactive compounds of Phyllanthus niruri modulate immune responses through cytokine regulation. Frontiers in Immunology, 13, 859134. 

George, B. P., Abrahamse, H., & Parimelazhagan, T. (2020). Caspase-dependent apoptosis induced by standardized Phyllanthus niruri extract in human hepatocellular carcinoma cell lines. BMC Complementary Medicine and Therapies, 20(1), 321. 

Ghosh, T., Maity, T. K., Bose, A., & Dash, D. K. (2014). Triterpenoids as potential chemo preventive and therapeutic agents: Evidence from preclinical and clinical studies. Phytomedicine, 21(2), 232–243.

Giribabu, N., Rao, P. V., Kumar, K. P., Muniandy, S., Rekha, S. S. & Salleh, N. (2014). Aqueous extract of Phyllanthus niruri leaves displays in vitro antioxidant activity and prevents the elevation of oxidative stress in the kidney of streptozotocin-induced diabetic male rats. Evid-Based Complement Alternat Med 2014: 1–10.

Gupta, A., Tiwari, S., & Singh, R. (2020). Immunomodulatory potential of Phyllanthus niruri extracts: Insights into cellular and molecular mechanisms. Journal of Ethnopharmacology, 258, 112893. 

Harish, R., & Shivanandappa, T. (2006). Antioxidant activity and hepatoprotective potential of Phyllanthus niruri. Food Chemistry, 95(2), 180–185. 

Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015). The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery, 14(2), 111–129.

Jesus, M., Martins, A. P., Gallardo, E., & Silvestre, S. (2016). Diosgenin: Recent highlights on pharmacology and analytical methodology. Journal of Analytical Methods in Chemistry, 2016, 4156293.

Kumar, S., Pandey, A. K., & Pandey, V. P. (2014). Phytochemistry, pharmacological activities, and future prospects of Phyllanthus species. Journal of Pharmacognosy and Phytochemistry, 3(4), 23–35.

Lee, C. C., Kuo, C. L., Wang, J. P., & Ho, F. M. (2022). Chemomodulatory role of Phyllanthus niruri fractions in enhancing doxorubicin sensitivity of resistant breast cancer cells. Journal of Ethnopharmacology, 289, 115005. 

Lee, C. D., Ott, M., & Thyagarajan, S. P. (2016). Phyllanthin and hypophyllanthin: Lignans of Phyllanthus species with potent anti-HBV activity. Frontiers in Pharmacology, 7, 199.

Lee, C. D., Ott, M., Thyagarajan, S. P., Shafritz, D. A., Burk, R. D., Gupta, S., & Shafritz, R. (1996). Phyllanthus amarus down-regulates hepatitis B virus messenger RNA transcription and replication. European Journal of Clinical Investigation, 26(12), 1069–1076. 

Lim, Y. M., Lee, S. H., Tan, B. C., & Lim, C. W. (2016). Pharmacological potential of Phyllanthus niruri: A review of preclinical and clinical studies. Phytotherapy Research, 30(7), 1104–1115.

Lin, C. C., Lin, T. Y., Chiang, L. C., & Lin, C. C. (2013). Antiviral activities of flavonoids and coumarins from Phyllanthus species. Planta Medica, 79(10), 835–840.

Mohammadhosseini, M., Venditti, A., Sarker, S. D., Nahar, L. & Akbarzadeh, A. (2019). The genus Ferula: Ethnobotany, phytochemistry and bioactivities – A review. Ind. Crop Prod., 129, 350-394.

Maia, F. C., Wijesinghe, G. K., de Oliveira, T. R., Barbosa, J. P., de Feiria, S. B., Boni, G. C., & Höfling, J. F. (2020). Phyllanthus niruri L. (stone-breaker) as an alternative of anti-human diseases, antimicrobial agent, and its applicability to combat resistant microorganisms. A brief review. Brazilian Journal of Natural Sciences, 3(2), 342–342

Meena, A. K., Panda, P., & Ramesh, B. (2021). Immunostimulatory and anti-inflammatory effects of Phyllanthus niruri in experimental models. Journal of Ayurveda and Integrative Medicine, 12(3), 487–494. 

Metabolomics study (2016). Metabolic and biochemical changes in streptozotocin induced obese-diabetic rats treated with Phyllanthus niruri extract. Journal Name. [PubMed]

Notka, F., Meier, G. R., & Wagner, R. (2004). Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Research, 64(2), 93–102.

Ottow, F. (1861). Über das Phyllanthin. Annalen der Chemie und Pharmacie, 119(1), 24–31.

Patel, J. R., Tripathi, P., Sharma, V., Chauhan, N. S., & Dixit, V. K. (2011). Phyllanthus amarus: Ethnomedicinal uses, phytochemistry and pharmacology: A review. Journal of Ethnopharmacology, 138(2), 286–313.

Prasad, K. N., Yang, B., Dong, X., Jiang, G., Zhang, H., Xie, H., & Jiang, Y. (2011). Flavonoid contents and antioxidant activities from Citrus peel extracts. Food Chemistry, 129(2), 527–533.

Preeja, R. P., Arivarasu, L., & Rajeshkumar, S. (2020). Antimicrobial and antioxidant activity of Phyllanthus niruri-mediated silver nanoparticles. Plant Cell, Biotechnology and Molecular Biology, 21(29–30), 30–37.

Radha, P., & Saranya, J. (2020). In vitro antioxidant activity of Phyllanthus niruri leaf extracts. Journal of Pharmacognosy and Phytochemistry, 9(3), 198–201.

Rajeshkumar, S., Preeja, R. P., & Arivarasu, L. (2020). Antioxidant and anti-inflammatory potential of Phyllanthus niruri-mediated silver nanoparticles. Plant Cell Biotechnology and Molecular Biology, 21(29–30), 30–37.

Rajeshkumar, S., Preeja, R. P., & Arivarasu, L. (2021). Anticancer efficacy of Phyllanthus niruri-derived phytoconstituents and nanoparticle formulations. Journal of Natural Medicines, 75(4), 863–872. 

Rani, A., & Sharma, R. (2021). Anti-inflammatory potential of Phyllanthus niruri extracts via suppression of pro-inflammatory cytokines in macrophages. Journal of Ethnopharmacology, 268, 113576. 

Rizvi, A., Khan, M. A., & Kumar, V. (2021). Phytochemicals of Phyllanthus niruri as multitarget anticancer agents: Insights from preclinical studies. Phytomedicine, 90, 153638. 

Sharma, A., Sharma, S., & Singh, H. (2011). Hepatoprotective activity of Phyllanthus niruri against paracetamol and ethanol induced hepatotoxicity in albino rats. International Journal of Pharmaceutical Sciences and Research, 2(2), 498–506.

Santwana Rani and Baidyanath Kumar (2015).Efficacy of Phyllanthus niruri Linn. Extract in the Management of Type-2 Diabetes Mellitus Associated Hypercholesterolemia in Mice Diabetic Model. Int. J. Curr. Microbiol. App. Sci., 4(6), 507-513.

Srinivasan, R., Chandrasekar, M. J., Nanjan, M. J., & Suresh, B. (2014). Antioxidant activity of some natural plant products: Evaluation by non-enzymatic methods. Pharmacognosy Reviews, 8(16), 130–134.

Srivastava, R., & Shukla, Y. (2010). Antimicrobial and pharmacological aspects of alkaloids: An update. Asian Journal of Pharmaceutical and Clinical Research, 3(1), 22–27.

Syamasundar, K. V., Singh, B., Thakur, R. S., Husain, A., Kiso, Y., & Hikino, H. (1985). Antihepatotoxic principles of Phyllanthus niruri herbs. Journal of Ethnopharmacology, 14(1), 41–44.

Tan, Y., Yang, J., Zhang, H., & Li, W. (2021). Phyllanthin and hypophyllanthin modulate autophagy and apoptosis in resistant breast cancer cells to enhance doxorubicin efficacy. ACS Omega, 6(15), 10132–10141. 

Tewari, D., Mocan, A., Parvanov, E. D., Sah, A. N., Nabavi, S. M., & Atanasov, A. G. (2017). Ethnopharmacological approaches for therapy of jaundice: Part II. Highly used plant species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae families. Frontiers in Pharmacology, 8, 519.

Thyagarajan, S. P., Jayaram, S., Gopalakrishnan, V., Hari, R., Jeyakumar, P., & Sripathi, M. S. (1988). Herbal medicines for liver diseases in India. Journal of Gastroenterology and Hepatology, 3(3), 203–206. 

Thyagarajan, S. P., Subramanian, S., Thirunalasundari, T., Venkateswaran, P. S., & Blumberg, B. S. (1988). Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. The Lancet, 332(8614), 764–766. 

Venkateswaran, P. S., Millman, I., & Blumberg, B. S. (1987). Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: In vitro and in vivo studies. Proceedings of the National Academy of Sciences, 84(1), 274–278.

Vieira, C., Evangelista, S., Cirillo, R., Lippi, A., Maggi, C. A., Manzini, S., & Parente, L. (2001). Effect of ricinoleic acid in acute and subchronic experimental models of inflammation. Mediators of Inflammation, 10(1), 29–33.

Wang, L., Li, W., & Ma, Y. (2014). Hepatoprotective and antiviral properties of Phyllanthus niruri extract in hepatitis B virus-infected patients. Journal of Medicinal Plants Research, 8(15), 599–606.

Wansi, J.D., Sewald, N., Nahar, L., Martin, C. & Sarker, S.D. (2019). Bioactive essential oils from the Cameroonian rain forest: A review - Part II. Trends Phytochem. Res. 3(1), 3-52

Yang, C. M., Cheng, H. Y., Lin, T. C., Chiang, L. C., & Lin, C. C. (2007). The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-β-D-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. Journal of Ethnopharmacology, 110(3), 555–558.

Yang, J., Lee, C. H., & Kim, S. W. (2020). Synergistic effects of Phyllanthus niruri lignans with chemotherapeutics in multidrug-resistant cancer cells. Frontiers in Oncology, 10, 512. 

How to cite this article

B. Sreedevi, C. Raja Kumar and P. Sashikiran (2023). Phytochemical and Pharmacological Properties of Phyllanthus niruri L: A Comprehensive Review. Biological Forum – An International Journal, 15(6): 1095-1100.